Drug discovery Archives

longevity treatment bioAge Kristen Fortney

Interview 31 Oct 2022

AI and biobanks could open the way to longevity treatments

The development of longevity treatments is hampered by a lack of biomarkers and validated drug targets. BioAge’s co-founder and CEO, Kristen Fortney, explains how the firm is enlisting machine learning…

October 31, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2022

Partnership between Paradigm4 and Alnylam accelerates drug target discovery

New genetically-validated drug targets are found at accelerated speed using population scale biobank genotype-phenotype datasets after a foundational partnership is formed between Paradigm4 and Alnylam. Paradigm4’s REVEAL integrative analytics platform…

October 26, 2022 - 3 minutesmins - By Liza Laws

cancer cell screening drug discovery microplate

News and Trends 26 Oct 2022

Recursion announces $150M private placement

U.S. biotech Recursion Pharmaceuticals has entered into a stock purchase agreement for the sale of an aggregate of approximately 15.3 million shares of its Class A common stock in a…

October 26, 2022 - 2 minutesmins - By Jim Cornall

Mike Nally Generate Biomedicines ai drug discovery

Interview 12 Oct 2022

Boosting pharma’s falling productivity with AI in drug discovery

The pharmaceutical industry is struggling with mounting costs of drug development. Generate Biomedicines’ CEO, Michael Nally, outlines the firm’s mission to tackle the trend by making drug discovery scalable. Over…

October 12, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 22 Sep 2022

Emyria starts program with neuroscience drug discovery CRO

Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics, a specialist neuroscience preclinical drug discovery and contract research organization (CRO). Emyria and partner, the University of Western…

September 22, 2022 - 2 minutesmins - By Jim Cornall

Startup Scout 22 Sep 2022

Cartography Biosciences unearths cancer immunotherapy targets

Despite its meteoric growth in the last twenty years, cancer immunotherapy research is hamstrung by a lack of viable drug targets. Cartography Biosciences is using a single-cell sequencing approach to…

September 22, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 21 Sep 2022

Collaboration will allow Evotec to evaluate small molecules developed by Adapsyn

Chemical bioinformatics company, Adapsyn Bioscience Inc., and Evotec SE have entered into a strategic collaboration that will allow Evotec to have the opportunity to evaluate the small molecules developed by…

September 21, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Sep 2022

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

In a deal with a potential value of $110 million over the next five years, CytoReason has announced an extension of its multi-year partnership with Pfizer. Pfizer will make a…

September 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 14 Sep 2022

Recursion adds FAP and C. diff clinical trials

Recursion Pharmaceuticals has initiated two additional clinical trials including its first in-house generated new chemical entity to enter the clinic. The phase 2 TUPELO clinical trial is evaluating REC-4881 for…

September 14, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Sep 2022

Proxidrugs: a new tool to fight pathogens?

Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP in Germany are working with partners to develop a new drug class. Proxidrugs (or proximity-inducing drugs) utilize cells’ waste…

September 1, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 15 Jun 2022

Japan’s five hottest biotech companies in healthcare

While historically lacking in foreign investments, Japan’s biotech scene is thriving with global investors showing increasing interest. Here are five of the hottest Japanese private companies innovating in the healthcare…

June 15, 2022 - 6 minutesmins - By Jonathan Smith

Infographics by

1 Mar 2022

Infographic: Drugging the Undruggable: Leveraging the Right Screening Methods for Challenging Targets

Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past. However, today a variety of screening methods can be used to help develop drugs against…

March 1, 2022 - 2 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 19 Jan 2022

Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration

With the close of its Series A round at €48M ($54M), the tissue models company Engitix has shifted its business from providing drug discovery services to developing its own treatment…

January 19, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 17 Jan 2022

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant Novo Nordisk to search for treatments controlling food intake and other factors contributing to obesity. …

January 17, 2022 - 3 minutesmins - By Dan Samorodnitsky

News and Trends 11 Jan 2022

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the French giant Sanofi has sealed a €4.6B deal with the UK AI player Exscientia to…

January 11, 2022 - 4 minutesmins - By Jonathan Smith

Interview 10 Jan 2022

Leveraging Physics and Quantum Computing to Accelerate Drug Discovery

Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and co-founder of Qubit Pharmaceuticals, discusses the potential of physics to accelerate drug discovery. Paris-based Qubit…

January 10, 2022 - 9 minutesmins - By External Contributor

News and Trends 7 Oct 2021

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the…

October 7, 2021 - 5 minutesmins - By Mark Zipkin

artificial intelligence, AI, computer-aided drug design, drug discovery

Artificial Intelligence: A Road to Faster and Better Drug Discovery?

Artificial intelligence (AI) has become a part of everyday modern life and continues to generate excitement. In this article, we will take a look at how biotechs are advancing into…

September 28, 2021 - 6 minutesmins - By Alexander Burik

Opinion 31 Aug 2021

Cloud Foundations for R&D: Designing the Future of Life Sciences

In recent years, artificial intelligence has been hailed as the next big thing in drug discovery. But to leverage the full potential of this technology the life sciences industry first…

August 31, 2021 - 7 minutesmins - By External Contributor

AI, disease models, cancer drug development, artificial intelligence

Using AI to Select the Right Disease Model for Cancer Drug Development

Researchers looking to cure cancer are constantly searching for disease models that closely resemble human physiology for testing cancer-fighting drugs. Artificial Intelligence (AI) can help researchers sift through large amounts…

July 20, 2021 - 8 minutesmins - By Sudha Sundaram

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering